These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11044823)

  • 21. [[Treatment with danaparoid during pregnancy for a woman with a cutenous allergy to low-molecular-weight heparin] ].
    de Saint-Blanquat L; Simon L; Toubas MF; Hamza J
    Ann Fr Anesth Reanim; 2000 Dec; 19(10):751-4. PubMed ID: 11200764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.
    de Valk HW; Banga JD; Wester JW; Brouwer CB; van Hessen MW; Meuwissen OJ; Hart HC; Sixma JJ; Nieuwenhuis HK
    Ann Intern Med; 1995 Jul; 123(1):1-9. PubMed ID: 7539233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.
    Grocott HP; Root J; Berkowitz SD; deBruijn N; Landolfo K
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):875-7. PubMed ID: 9412888
    [No Abstract]   [Full Text] [Related]  

  • 24. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.
    Insler SR; Kraenzler EJ; Bartholomew JR; Kottke-Marchant K; Lytle B; Starr NJ
    Anesthesiology; 1997 Feb; 86(2):495-8. PubMed ID: 9054269
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 27. [Danaparoid for anticoagulation with Cell Saver 5. Answer to the letter of A. Lorentz].
    von Lüpke U
    Anaesthesist; 2001 Oct; 50(10):793. PubMed ID: 11702331
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
    Fernandes P; Mayer R; MacDonald JL; Cleland AG; Hay-McKay C
    Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis.
    Schmahl KS; Ganjoo AK; Harloff MG
    J Cardiothorac Vasc Anesth; 1997 Apr; 11(2):262-3. PubMed ID: 9106004
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.
    Polkinghorne KR; McMahon LP; Becker GJ
    Am J Kidney Dis; 2002 Nov; 40(5):990-5. PubMed ID: 12407644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is it safe and cost effective... Danaparoid (Orgaran) as an anticoagulant for mechanical autotransfusion with Cell Saver 5 (Hemonetics),Anaesthesist (2001) 50:26-31].
    Lorentz A
    Anaesthesist; 2001 Oct; 50(10):792. PubMed ID: 11702330
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
    Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment.
    Dworschak M; Hiesmayr JM; Lassnigg A
    Ann Thorac Surg; 2002 May; 73(5):1626-7. PubMed ID: 12022563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids.
    Boehncke WH; Weber L; Gall H
    Contact Dermatitis; 1996 Aug; 35(2):73-5. PubMed ID: 8917822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
    Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Danaparoid sodium lowers proteinuria in diabetic nephropathy.
    van der Pijl JW; van der Woude FJ; Geelhoed-Duijvestijn PH; Frölich M; van der Meer FJ; Lemkes HH; van Es LA
    J Am Soc Nephrol; 1997 Mar; 8(3):456-62. PubMed ID: 9071714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a high-pressure liquid chromatography method for diagnosis of heparin-induced thrombocytopenia.
    Koch S; Harenberg J; Odel M; Schmidt-Gayk H; Walch S; Budde U
    Am J Clin Pathol; 2002 Jun; 117(6):900-4. PubMed ID: 12047141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current treatment concepts in heparin-induced thrombocytopenia].
    Ranze O; Greinacher A
    Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
    [No Abstract]   [Full Text] [Related]  

  • 40. Danaparoid is not a low-molecular-weight heparin.
    Nicholson CD; Meuleman DG; Magnani HN; Egberts JF; Leibowitz DA; Spinler SA; Cziraky MJ
    Am J Hosp Pharm; 1994 Aug; 51(16):2049-50. PubMed ID: 7526686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.